loadpatents
Patent applications and USPTO patent grants for Boehmelt; Guido.The latest application filed is for "2,4-diamino-pyrimidines as aurora inhibitors".
Patent | Date |
---|---|
Pyridons as PDK1 inhibitors Grant 8,637,549 - Engelhardt , et al. January 28, 2 | 2014-01-28 |
Compounds Grant 8,623,887 - Zahn , et al. January 7, 2 | 2014-01-07 |
2,4-diamino-pyrimidines As Aurora Inhibitors App 20130281429 - ZAHN; Stephan Karl ;   et al. | 2013-10-24 |
Substituted 9H-purin-2-YL compounds, compositions thereof and uses thereof Grant 8,404,674 - Stadtmueller , et al. March 26, 2 | 2013-03-26 |
4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments Grant 8,258,129 - Engelhardt , et al. September 4, 2 | 2012-09-04 |
Substituted indolines as tyrosine kinase inhibitors Grant 8,207,179 - Engelhardt , et al. June 26, 2 | 2012-06-26 |
Heterocyclyl Carbonic Acid Amides As Antiproliferative Agents, Pdkl Inhibitors App 20110313156 - Engelhardt; Harald ;   et al. | 2011-12-22 |
Pyridons As Pdk1 Inhibitors App 20110269958 - Engelhardt; Harald ;   et al. | 2011-11-03 |
2,4-diamino-pyrimidines As Aurora Inhibitors App 20110251174 - ZAHN; Stephan Karl ;   et al. | 2011-10-13 |
Compounds App 20100311721 - Stadtmueller; Heinz ;   et al. | 2010-12-09 |
New Compounds App 20100222331 - Engelhardt; Harald ;   et al. | 2010-09-02 |
Compounds App 20100144706 - Zahn; Stephan Karl ;   et al. | 2010-06-10 |
4-heterocycloalkylpyri(mi)dines, Process For The Preparation Thereof And Their Use As Medicaments App 20090203673 - Engelhardt; Harald ;   et al. | 2009-08-13 |
2,4-diaminopyrimidines useful for treating cell proliferation diseases Grant 7,569,561 - Stadtmueller , et al. August 4, 2 | 2009-08-04 |
New compounds App 20090163467 - Zahn; Stephan Karl ;   et al. | 2009-06-25 |
New Compounds App 20070207999 - Stadtmueller; Heinz ;   et al. | 2007-09-06 |
2,4-diamino-pyrimidines as aurora inhibitors App 20070032514 - Zahn; Stephan Karl ;   et al. | 2007-02-08 |
Methods for producing differentiated cells from immature hematopoietic cells Grant 5,648,248 - Zenke , et al. July 15, 1 | 1997-07-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.